Skip to main content
. 2016 Mar 14;7(16):22234–22244. doi: 10.18632/oncotarget.8067

Figure 3. Protein expression levels of FGFR2 and FGFR4 and their prognostic role in MPNST.

Figure 3

(A) FGFR2 protein expression in a representative human MPNST tissue sample (20×). (B) FGFR2 protein expression in a representative human MPNST tissue sample (40×). (C) Overall survival (OS) of 61 MPNST patients based on FGFR1 and FGFR2 expression status. (D) FGFR4 protein expression in a representative human MPNST tissue sample (20×). (E) FGFR4 protein expression in a representative human MPNST tissue sample (40×). (F) OS of 62 MPNST patients based on FGFR4 expression status.